Trending...
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- California: Governor Newsom announces appointments 12.12.2025
- Ventura College Foundation Distributes Record $1.16 Million in Direct Student Support
THOUSAND OAKS, Calif., June 12, 2024 ~ Omeat, a leading biotechnology company, has recently released a white paper detailing the success of their product, Plenty. This nutrient-rich supplement is a humane and cost-effective replacement for Fetal Bovine Serum (FBS), commonly used in cell culture.
Plenty was first launched last year as an ethical alternative to FBS. It is derived from the plasma of living cows and is enriched with platelet lysate, which contains regenerative growth factors. These factors play a crucial role in organ regeneration and cell growth and differentiation.
One of the major advantages of Plenty is its affordability. The process of collecting enriched plasma from cows is more efficient and humane compared to the traditional method of collecting FBS, which involves the slaughter of pregnant cows and their fetuses. This not only makes Plenty more cost-effective but also adheres to high animal welfare standards.
The white paper released by Omeat includes results from independent studies conducted by prestigious research universities worldwide. These studies have shown that Plenty's performance is comparable to or even surpasses that of FBS in supporting cell growth in 15 different cell lines. This validates Plenty's efficacy and reliability as a cell culture supplement.
More on The Californer
Some of the institutions that have evaluated Plenty include Stanford University, Boston University, Emory University, Syracuse University, Johns Hopkins University, UCLA, Virginia Tech, Northeastern University, and Universitätsklinikum Erlangen. With such positive results from reputable sources, Plenty has the potential to revolutionize various industries and research fields such as drug discovery, cancer research, and neurodegenerative disease studies.
Plenty can be purchased directly from http://getplenty.bio at an introductory price of $200 per 500mL bottle and $50 per 60mL sample. These prices are significantly lower than those of FBS, making it an attractive option for researchers and companies alike.
Omeat's commitment to animal welfare is evident in their selection of cows that are free of zoonotic diseases and allowed to graze freely on a large pasture. This eliminates the need for environmentally destructive feedlots, making Plenty a sustainable and ethical choice.
With its proven success and ethical production process, Plenty has the potential to be a game-changer in the world of cell culture. Researchers and companies can now have access to a cost-effective and humane alternative to FBS, thanks to Omeat's innovative product.
Plenty was first launched last year as an ethical alternative to FBS. It is derived from the plasma of living cows and is enriched with platelet lysate, which contains regenerative growth factors. These factors play a crucial role in organ regeneration and cell growth and differentiation.
One of the major advantages of Plenty is its affordability. The process of collecting enriched plasma from cows is more efficient and humane compared to the traditional method of collecting FBS, which involves the slaughter of pregnant cows and their fetuses. This not only makes Plenty more cost-effective but also adheres to high animal welfare standards.
The white paper released by Omeat includes results from independent studies conducted by prestigious research universities worldwide. These studies have shown that Plenty's performance is comparable to or even surpasses that of FBS in supporting cell growth in 15 different cell lines. This validates Plenty's efficacy and reliability as a cell culture supplement.
More on The Californer
- The International Songwriters Day Song Contest Launches!
- 2025 Aquila Polonica Article Prize Winner Announced
- The Womens Freedom Song Contest Launches!
- Ventura Chamber of Commerce Names Cumulus Media VP Sommer Frisk "Shining Star of the Year"
- City of Long Beach to Host Second Business Networking Event Along Santa Fe Avenue Corridor
Some of the institutions that have evaluated Plenty include Stanford University, Boston University, Emory University, Syracuse University, Johns Hopkins University, UCLA, Virginia Tech, Northeastern University, and Universitätsklinikum Erlangen. With such positive results from reputable sources, Plenty has the potential to revolutionize various industries and research fields such as drug discovery, cancer research, and neurodegenerative disease studies.
Plenty can be purchased directly from http://getplenty.bio at an introductory price of $200 per 500mL bottle and $50 per 60mL sample. These prices are significantly lower than those of FBS, making it an attractive option for researchers and companies alike.
Omeat's commitment to animal welfare is evident in their selection of cows that are free of zoonotic diseases and allowed to graze freely on a large pasture. This eliminates the need for environmentally destructive feedlots, making Plenty a sustainable and ethical choice.
With its proven success and ethical production process, Plenty has the potential to be a game-changer in the world of cell culture. Researchers and companies can now have access to a cost-effective and humane alternative to FBS, thanks to Omeat's innovative product.
Filed Under: Business
0 Comments
Latest on The Californer
- Sonet.io Unveils Safer Enterprise Architecture for AI Agents Without Internet Exposure
- New Year's Business Resolution Number One: Start using this very effective Marketing Math Today!
- Tru by Hilton Columbia South Opens to Guests
- Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
- As Donald Trump attempts to restrict health care for LGBTQ youth, California partners with The Trevor Project to launch statewide suicide prevention training for 988 crisis counselors
- "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Americans Just Spent $44 Billion Online in Five Days — And Smart Entrepreneurs Are Cashing In Year-Round
- Long Beach Open Coastal Swimming Areas Temporarily Closed Due to Sewage Spill
- New Analysis from Eric Galuppo Links Reactive Management to System Design Failures
- City of Long Beach Facilities and Services Schedule for Christmas Day and New Year's Day
- Long Beach Airport's Rental Car Services Move into Historic Terminal
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
- Why Buying a Home at Christmas will be Your Best Christmas Ever
- Community Commitment Advances Student Opportunity at Moorpark College
- Rachel Farris, CPA, Founder of Tax Stack AI, Featured in Boss Today on Ethical AI Leadership
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
- The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue